P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer (Q42477262)

1 November 2017

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer (English)

1 reference

1 November 2017

0 references

1

Gulisa Turashvili

1 reference

1 November 2017

Steven E McKinney

2

1 reference

1 November 2017

Ozge Goktepe

3

1 reference

1 November 2017

Samuel C Leung

4

1 reference

1 November 2017

David G Huntsman

5

1 reference

1 November 2017

Karen A Gelmon

6

1 reference

1 November 2017

Gerrit Los

7

1 reference

1 November 2017

Paul A Rejto

8

1 reference

1 November 2017

Samuel A J R Aparicio

9

1 reference

1 November 2017

17 September 2010

1 reference

1 November 2017

1 reference

1 November 2017

24

1 reference

1 November 2017

1

1 reference

1 November 2017

64-81

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.189

1 November 2017

0 references

cites work

Roles of E- and P-cadherin in the human skin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Cadherins in cutaneous biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Soluble N-cadherin in human biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

P-cadherin expression in breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Precocious mammary gland development in P-cadherin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Cadherins and the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

P-cadherin as a marker in the differential diagnosis of breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Triple-negative breast cancer--current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Tissue microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Frequency of the basal-like phenotype in African breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Reporting bias in diagnostic and prognostic studies: time for action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Immunohistochemical staining of papillary breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Do 'basal-like' breast cancers really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

A mouse model of basal-like breast carcinoma with metaplastic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Expression of BRCA1 protein in breast cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Functional characterization of E- and P-cadherin in invasive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Cadherins and catenins in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

The role of epithelial-mesenchymal transition in cancer pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Induction and regulation of epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

A 'good death' for tumor immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Aberrant P-Cadherin Expression: Is it Associated with Estrogen-Independent Growth in Breast Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

Isolation of placental cadherin cDNA: identification of a novel gene family of cell-cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Soluble fragment of P-cadherin adhesion protein found in human milk

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Cadherins as predictive markers of nodal metastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Distinct cadherin profiles in special variant carcinomas and other tumors of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Triple negative tumours: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

Mutations of the human E-cadherin (CDH1) gene.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.189

7 January 2021

10.1038/MODPATHOL.2010.189

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference